Kraig Biocraft Laboratories, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Kraig Biocraft Laboratories, Inc.'s Chief Operating Officer, Jonathan Rice, has increased his direct beneficial ownership by exercising warrants to acquire 314,636 shares of Class A Common Stock.
OQB
Kimberly Kraig Thompson, CEO of Kraig Biocraft Laboratories, Inc., acquired 27,500 shares of common stock at a price of $0.0906 per share on March 31, 2025.
OQB
Kimberly Kraig Thompson, CEO of Kraig Biocraft Laboratories, reports the acquisition of 62,500 shares of common stock at a price of $0.0906 per share on March 31, 2025.
OQB
Chief Operating Officer of Kraig Biocraft Laboratories, Jonathan Richard Rice, recently exercised stock options, increasing his holdings in Class A Common Stock.